Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

197.01 -0.68 (-0.34%)
Official Closing Price Updated: 7:00 PM EDT, Sep 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,214,519
Open 198.68
Bid (Size) 196.51 (1)
Ask (Size) 198.02 (6)
Prev. Close 197.69
Today's Range 196.44 - 199.88
52wk Range 135.85 - 199.95
Shares Outstanding N/A
Dividend Yield 3.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures COVID-19
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga

Performance

YTD
+23.27%
+23.27%
1 Month
+6.86%
+6.86%
3 Month
+21.51%
+21.51%
6 Month
+9.96%
+9.96%
1 Year
+34.85%
+34.85%

More News

Read More
2 Dividend Stocks You Can Safely Hold Through a Recession
Via The Motley Fool
AbbVie Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
AbbVie Unusual Options Activity For August 26
Via Benzinga
Key Takeaways From AbbVie Analyst Ratings
Via Benzinga
Unpacking the Latest Options Trading Trends in AbbVie
Via Benzinga
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
From FN Media Group LLC
Via GlobeNewswire
2 High-Yield Dividend Stocks to Buy in September and Hold for a Decade or Longer
Via The Motley Fool
Stock Market Rally Mixed; Dow Jones Hits High While Nvidia Tumbles On Earnings: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher
Via The Motley Fool
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
Via The Motley Fool
2 Incredibly Cheap Healthcare Stocks to Buy Now
Via The Motley Fool
Biotech And Life Science Sector Update Summer Of 2024
Via Talk Markets
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
Via The Motley Fool
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
Via Benzinga
Neurocrine Bio Dives As Schizophrenia Trial Results Lags Peers
Via Investor's Business Daily
3 Best Growth Stocks to Own for the Next 10 Years
Via MarketBeat
Topics Economy
Exposures Economy
Prediction: Eli Lilly's Latest Move Will Threaten AbbVie Stock
Via The Motley Fool
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
Via Benzinga
Donald Trump Owns These 21 Dividend Kings. Should You?
Via The Motley Fool
Topics Government
Exposures Political
3 Unstoppable Dividend Stocks to Buy Right Now
Via The Motley Fool
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
Via Benzinga
How To Build A Dividend Growth Portfolio In An Overpriced Market
Via Talk Markets
Topics Stocks
Exposures US Equities
Biotech Bull Market: 3 Ways To Play It
Via Talk Markets
Topics Economy
Exposures Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.